Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

NCT00633139 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Late Infantile Metachromatic Leukodystrophy

Interventions

BIOLOGICAL: Recombinant human Arylsulfatase A (rhASA)

Sponsor

Shire